Area Legislators Learn about the Potential of RNA Research at UAlbany

Recently, Paul Agris, the director of The RNA Institute at the University at Albany, welcomed Albany, NY-based legislators to his cutting-edge facility to learn more about the research, innovation, and business collaborations happening at the Institute.

What did they learn that you should also know?

• RNA builds proteins using the instructions in our genes. As a novel therapeutic drug class, RNA has the potential to address problems at any step of protein building, preventing the production of an abnormally made protein that triggers disease. Be sure to check out our RNA infographic for a more visual description.

• The RNA Institute possesses both leadership and an established team driven toward common goals. More than equipment and space, the Institute is made up of a network of people whose intellectual capital and creative problem solving are at the cutting edge of biotechnology and entrepreneurship.

• The Institute has already demonstrated its ability to leverage returns on State support such as the CREDC CFA Award. With the CAT, the Institute will have a significant multiplier in credibility to leverage State support into greater returns.

• Job creation is an intrinsic part of the Institute's mission and organic growth in the biotech sector.

• Interactions with corporations are already well underway at The RNA Institute. Recognition at the State level, would grant the Institute a critical mass of credibility necessary to serve as a magnet to recruit biopharma to NY.

To learn more about the potential of RNA research and this world-class facility, please contact The RNA Institute Director, Dr. Paul Agris at (518) 437-4448.

For more news, subscribe to UAlbany's RSS headline feeds